Ocular allergy/inflammation:

Indications for: ACUVAIL

Ocular pain and inflammation after cataract surgery.

Adult Dosage:

1 drop in the affected eye twice daily beginning 1 day prior to surgery, continue on day of surgery and through first 2 weeks post-op. Concomitant other topical ophthalmics (eg, alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, mydriatics): administer at least 5 minutes apart.

Children Dosage:

Not established.

ACUVAIL Warnings/Precautions:

Do not administer while wearing contacts. Aspirin/NSAID sensitivity. Asthma. Bleeding tendencies. Complicated or repeated ocular surgeries. Corneal defects/denervation. Ocular surface diseases. Diabetes. Rheumatoid arthritis. May delay wound healing. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Pregnancy (Cat.C): avoid in late pregnancy. Nursing mothers.

ACUVAIL Classification:

NSAID.

ACUVAIL Interactions:

Concomitant topical steroids may increase potential for healing problems.

Adverse Reactions:

Increased intraocular pressure, conjunctival hyperemia and/or hemorrhage, corneal edema, ocular pain, headache, tearing, blurred vision; keratitis, increased ocular bleeding (including hyphemas).

Metabolism:

Hepatic. >99% serum protein bound.

Drug Elimination:

Renal.

How Supplied:

Single-use vials (0.4mL)—30